Venereal Disease Research Laboratory

 

VDRL (Venereal Disease Research Laboratory) Test

Definition

The VDRL Test is a non-treponemal serological test used to screen for syphilis, a sexually transmitted infection caused by Treponema pallidum. It detects reagin antibodies produced in response to cellular damage caused by the infection, rather than antibodies against the bacterium itself.


Principle

The VDRL test is based on a flocculation reaction. When a patient's serum containing reagin antibodies is mixed with a cardiolipin-lecithin-cholesterol antigen, visible clumping (flocculation) occurs if the test is positive.


Objectives

1. To screen for syphilis infection.

2. To aid in the diagnosis of syphilis.

3. To monitor the effectiveness of syphilis treatment.

4. To detect congenital syphilis in appropriate clinical settings.

5. To identify individuals who require confirmatory treponemal testing.



Materials Required

Patient serum sample

VDRL antigen suspension

VDRL test slide

Mechanical rotator

Micropipettes and tips

Positive and negative controls

Gloves and PPE


Procedure

1. Collect a venous blood sample and separate the serum.

2. Place the required volume of serum onto the VDRL test slide.

3. Add one drop of VDRL antigen to the serum.

4. Rotate the slide on a mechanical rotator for 4 minutes.

5. Examine the slide for flocculation under adequate lighting.

6. Record and interpret the results.

si zan
Observation

Reactive (Positive): Visible flocculation (clumping) is observed.

Non-Reactive (Negative): No visible flocculation.

Weakly Reactive: Minimal flocculation; confirmatory testing is recommended.


Advantages

Simple, rapid, and inexpensive.

Suitable for large-scale syphilis screening.

Useful for monitoring treatment response.

Widely available in clinical laboratories.


Limitations

The VDRL test is not specific for Treponema pallidum and may produce false-positive results in conditions such as pregnancy, autoimmune diseases, malaria, tuberculosis, or certain viral infections.

Early primary syphilis and late-stage syphilis may produce false-negative results.

Reactive VDRL results should always be confirmed with a treponemal test (e.g., TPHA, TPPA, or FTA-ABS).

Results should always be interpreted together with the patient's clinical findings and medical history. 


Comments

Post a Comment

Popular posts from this blog

ELISA (Enzyme-Linked Immunosorbent Assay) in Hematological Disorders

Image
  1. Objective The objective of the experiment was to detect and quantify disease-specific antigens or antibodies in hematological disorders using the ELISA technique. 2. Principle The ELISA technique was based on antigen-antibody interaction. Either the antigen or antibody was immobilized on a solid surface (usually a microtiter plate), and a corresponding enzyme-labeled antibody was used for detection. Upon addition of a chromogenic substrate, a color change occurred, which was measured spectrophotometrically and correlated with the concentration of the target molecule. 3. Materials Used Microtiter ELISA plate Patient serum or plasma samples Known standards and controls Enzyme-conjugated antibodies (e.g., anti-FVIII for Hemophilia A) Substrate (e.g., TMB – Tetramethylbenzidine) Stop solution (e.g., sulfuric acid) Plate washer and reader Pipettes and sterile tips 4. Procedure The microtiter plate was coated with capture antibody and incubated....
Read more

Antiphospholipid Antibody Test (e.g., dRVVT)

Image
  1. Objective: To detect antiphospholipid antibodies in patient plasma, especially in suspected cases of antiphospholipid syndrome, using the Dilute Russell’s Viper Venom Time (dRVVT) test. 2. Principle: The dRVVT measures the time it takes for plasma to clot after the addition of diluted Russell's viper venom, which directly activates factor X. In the presence of antiphospholipid antibodies, especially lupus anticoagulant, the clotting time is prolonged. A confirmatory test with excess phospholipids is used to demonstrate correction. 3. Materials Required: Patient citrated plasma Normal pooled plasma (control) Russell’s viper venom reagent (screening and confirmatory) Calcium chloride Platelet-poor plasma Coagulometer or water bath with stopwatch Test tubes and pipettes 4. Procedure: Collected citrated blood and prepared platelet-poor plasma. Added venom reagent to both patient and control plasma. Added calcium chloride to initiate clottin...
Read more

Antibiotic Sensitivity Test

Image
  1. Objective The objective of this test was to determine the  sensitivity of bacterial isolates  to various  antibiotic agents , helping guide effective antimicrobial therapy.   2. Principle The test was based on the  inhibition of bacterial growth  by antibiotics. The  Kirby-Bauer disc diffusion method  was used, where antibiotic-impregnated discs were placed on an agar plate inoculated with bacteria. The  zone of inhibition  around each disc indicated the effectiveness of the antibiotic. 3. Materials Pure bacterial isolate Mueller-Hinton agar plates Antibiotic discs (e.g., ampicillin, ciprofloxacin, ceftriaxone) Sterile swabs  McFarland standard (0.5) Incubator (35–37°C) Ruler or caliper CLSI guideline chart for interpretation 4. Procedure A standardized bacterial suspension (0.5 McFarland) was prepared. The suspension was evenly spread onto Mueller-Hinton agar using a sterile swab. Antibiotic discs were placed on the agar ...
Read more